H.C. Wainwright Reiterates Buy Rating on Arrowhead Pharma (ARWR)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Wall St edges lower as chips fall; markets assess big bank earnings
- Oil prices mixed as US-Russia diesel deal hopes offset Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 58.70 -2.03 (3.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.73 | 52 Week High | $8.22 | |||
| Open | $60.04 | 52 Week Low | $3.07 | |||
| Day High | $60.73 | P/E | N/A | |||
| Day Low | $58.22 | EPS | $-1.30 | |||
| Volume | 997,186 | |||||
